Skip to search formSkip to main contentSkip to account menu

microcin J25

Known as: MccJ25 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Nosocomial pathogens can cause life-threatening infections in neonates and immunocompromised patients. E. bugandensis (EB-247) is… 
2016
2016
Lasso peptides are natural products characterized by a mechanically interlocked topology. The conformation of lasso peptides has… 
2015
2015
Microcin J25 (MccJ25) is a 21-residue ribosomally synthesized bactericidal peptide produced by Escherichia coli strains with an… 
2006
2006
ABSTRACT Escherichia coli microcin J25 (MccJ25) is a plasmid-encoded antibiotic peptide consisting of 21 l-amino acid residues… 
2005
2005
ABSTRACT Peptide microcin J25 (MccJ25) inhibits bacterial RNA polymerase. We show that thermolysin-cleaved MccJ25 and MccJ25… 
Highly Cited
2001
Highly Cited
2001
Microcin J25 (MccJ25) is a cyclic peptide of 21 unmodified amino acid residues produced by a fecal strain of Escherichia coli. It… 
2001
2001
To screen, isolate, and characterize bacterial populations producing microcin J25, we report here two rapid, reliable, and…